Prenetics Global Ltd News - PRE

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the...

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic...

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

LONDON and HONG KONG, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”...

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

LONDON and HONG KONG, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”...

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

Revenue of US$51.7 million in the second quarter of 2022Loss from operations of US$(17.9) million and adjusted...

Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE.”

LONDON and HONG KONG, June 06, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”...

Prenetics Rings the Opening Bell and Debuts on Nasdaq

Prenetics becomes the first Hong Kong unicorn to list on Nasdaq and its shares began trading on May 18 under...

US EARNINGS WRAP: Amgen Profit Climbs, Zoran Loss Narrows

Below is a synopsis of major quarterly releases from Monday afternoon: Amgen Net Jumps On Revenue Bump, Boosts Year Earnings View Amgen Inc.'s...

Insurers Stuck Between Rising Costs And Suffering Customers

Forget about tropical storms as this year's hurricane season gets underway. Insurers are nervously eyeing a more immediate problem: The squeeze of...

PartnerRe to Release 2008 Third Quarter and Nine Month Results and Host Analyst Conference Call and Webcast

PEMBROKE, Bermuda, Oct. 15 /PRNewswire-FirstCall/ -- PartnerRe Ltd. (NYSE: PRE) today announced dates for its 2008 third quarter and nine month...

PartnerRe Ltd. Provides Preliminary Outlook on Third Quarter 2008 Results

PEMBROKE, Bermuda, Oct. 10 /PRNewswire-FirstCall/ -- PartnerRe Ltd. (NYSE: PRE) (the Company) today announced preliminary estimates of Non-Life...

CORRECTED: PartnerRe Ltd. Announces Redemption of 7.90% Capital Trust I Preferred Securities

PEMBROKE, Bermuda, Nov. 21 /PRNewswire-FirstCall/ -- CORRECTED -- PartnerRe Ltd. today announced that PartnerRe Capital Trust I will call for...

PartnerRe Ltd. Announces Redemption of 7.90% Capital Trust I Preferred Securities

PEMBROKE, Bermuda, Nov. 21 /PRNewswire-FirstCall/ -- PartnerRe Ltd. today announced that PartnerRe Capital Trust I will call for redemption all...

PartnerRe Ltd. President & CEO Patrick Thiele to Present at the UBS Global Financial Services Conference, New York

PEMBROKE, Bermuda, May 12 /PRNewswire-FirstCall/ -- PartnerRe Ltd. (NYSE: PRE) today announced that President & Chief Executive Officer Patrick...

PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Sha

PEMBROKE, Bermuda, Nov. 10 /PRNewswire-FirstCall/ -- PartnerRe Ltd. (NYSE: PRE) announced that its Board of Directors has declared a dividend...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Prenetics Global Ltd (PRE)

Empower your portfolio: Real-time discussions and actionable trading ideas.

PRE News

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE.”

Prenetics Rings the Opening Bell and Debuts on Nasdaq

US EARNINGS WRAP: Amgen Profit Climbs, Zoran Loss Narrows

Insurers Stuck Between Rising Costs And Suffering Customers

PartnerRe to Release 2008 Third Quarter and Nine Month Results and Host Analyst Conference Call and Webcast

PartnerRe Ltd. Provides Preliminary Outlook on Third Quarter 2008 Results

CORRECTED: PartnerRe Ltd. Announces Redemption of 7.90% Capital Trust I Preferred Securities

PartnerRe Ltd. Announces Redemption of 7.90% Capital Trust I Preferred Securities

PartnerRe Ltd. President & CEO Patrick Thiele to Present at the UBS Global Financial Services Conference, New York

PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Sha

PRE Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Prenetics Global Ltd (PRE) News

Prenetics Global Ltd (PRE)

Empower your portfolio: Real-time discussions and actionable trading ideas.

PRE News

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE.”

Prenetics Rings the Opening Bell and Debuts on Nasdaq

US EARNINGS WRAP: Amgen Profit Climbs, Zoran Loss Narrows

Insurers Stuck Between Rising Costs And Suffering Customers

PartnerRe to Release 2008 Third Quarter and Nine Month Results and Host Analyst Conference Call and Webcast

PartnerRe Ltd. Provides Preliminary Outlook on Third Quarter 2008 Results

CORRECTED: PartnerRe Ltd. Announces Redemption of 7.90% Capital Trust I Preferred Securities

PartnerRe Ltd. Announces Redemption of 7.90% Capital Trust I Preferred Securities

PartnerRe Ltd. President & CEO Patrick Thiele to Present at the UBS Global Financial Services Conference, New York

PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Sha

PRE Discussion

Your Recent History